Anita Koroknai

Dr. Anita Koroknai

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
AKAnita Koroknai
Anita Koroknai
ANAnna Nagy
Anna Nagy
ONOrsolya Nagy
Orsolya Nagy
NCNikolett Csonka
Nikolett Csonka
EMEszter Mezei
Eszter Mezei
MTMária Takács
Mária Takács
Lymphocytic choriomeningitis virus (LCMV) is a neglected rodent-borne arenavirus, primarily spread by common house mouse species. Acquired human infections range from asymptomatic to mild flu-like symptoms and self-resolving neurological diseases. In contrast, intrauterine LCMV infection is associated with high mortality and morbidity. Infection of the fetus often leads to fetal death, and surviving fetuses may develop vision impairment and central nervous system developmental disorders. LCMV is mainly diagnosed by serological methods using in-house indirect immunofluorescence assays. LCMV nucleic acid is detected by the nested RT-PCR method and confirmed by Sanger sequencing. In Hungary, 23 acquired lymphocytic choriomeningitis cases were diagnosed between 2017 and 2023. Ten out of 23 confirmed patients proved to be positive by the PCR method. Two cases of intrauterine LCMV infections were detected in 2019 and 2021, respectively. The IgG antibody titers measured in the infant’s serum samples were much higher than the IgG titers of the maternal serum samples. Both IgM and IgA antibodies were detectable in the infants’ sera. As the microbiological diagnosis of LCMV is rather challenging and the symptoms are very similar to the clinical picture of other common teratogenic pathogens such as cytomegalovirus or Toxoplasma gondii, intrauterine LCMV infections might still be underdiagnosed.

16 March 2026 in Viruses
Verified
Journal Article
Open access
PDF file
AKAnita Koroknai
Anita Koroknai
ANAnna Nagy
Anna Nagy
ONOrsolya Nagy
Orsolya Nagy
NCNikolett Csonka
Nikolett Csonka
LZLevente Zsichla
Levente Zsichla
MTMária Takács
Mária Takács
Hantaviruses are globally distributed, rodent-borne zoonotic pathogens. In Hungary, Dobrava-Belgrade virus (DOBV) and Puumala virus (PUUV) are circulating, causing hemorrhagic fever with renal syndrome and nephropathia epidemica, respectively. Due to the short viremic period, hantaviruses are primarily diagnosed by serological methods. Detection of viral nucleic acid by real-time or nested reverse transcription polymerase chain reaction (RT-PCR) is limited to samples collected in the early phase of disease. Between 2018 and 2025, 51 laboratory-confirmed hantavirus infections were identified in Hungary; 30 cases were assigned to DOBV, 20 to PUUV, and one remained undetermined. Most patients were male (82%), suggesting increased exposure-related risk. Viral RNA was detected in 21 cases, mainly from serum and whole blood samples, and sporadically from urine. In three DOBV cases, viral RNA was detectable exclusively in whole blood but not in paired serum samples. Phylogenetic analysis included four PUUV and six DOBV partial S segment sequences showing high similarity to other human- and rodent-derived samples from the region. Hantavirus infections remain infrequently diagnosed in Hungary. Our findings suggest that serum and whole blood may be useful specimen types for molecular detection, whereas urine had limited diagnostic value in our dataset.

23 April 2026 in Eurosurveillance
Verified
Journal Article
Open access
ANAnna Nagy
Anna Nagy
KEKároly Erdélyi
Károly Erdélyi
ZMZsuzsanna Molnár
Zsuzsanna Molnár
RLRenáta Bagóné Lőrincz
Renáta Bagóné Lőrincz
ONOrsolya Nagy
Orsolya Nagy
Daniel CadarDaniel Cadar
Daniel Cadar
BACKGROUND: West Nile virus (WNV) has become established across Europe, with Hungary serving as a key transmission hub since 2004. Following reduced activity during 2020–22, the 2024 season marked a resurgence with the largest geographical distribution ever recorded in Europe. AIM: To analyse the 2024 WNV transmission season in Hungary using a One Health approach and characterise circulating strains within the European phylogeographic context using comprehensive genomic surveillance. METHODS: Complete and near-complete genome sequencing was performed on 55 specimens from 38 humans, 15 birds and two Culex pipiens mosquito pools using amplicon-based next-generation sequencing. Phylogeographic analysis incorporated 637 European WNV genome sequences (2004–24) with time-scaled Bayesian phylogenetic reconstruction and continuous spatial diffusion modelling. RESULTS: Hungary reported 113 human WNV cases in 2024 (n = 111 autochthonous, 2 imported), a 3.7-fold increase from 2023 (incidence: 1.16 vs 0.31 per 100,000 population). Neuroinvasive disease predominated (92%, n = 104) with a 7.9% case fatality rate. All 55 sequenced strains belonged to WNV lineage 2. Phylogeographic analysis revealed Hungary's central role in European WNV dissemination since 2004, with multiple introductions and local diversification across distinct clades. Continuous spatial modelling identified Hungary as a persistent transmission hub with bidirectional viral flow to neighbouring countries, contributing to northward expansion. CONCLUSION: Hungary remains a critical WNV transmission hub in Central Europe with established endemicity of multiple lineage 2 clades. The analysis highlights Hungary's role as both a recipient and major source of European WNV diversity, emphasising the need for coordinated surveillance and climate-adapted preparedness strategies.